Atlantic Research Group

Atlantic Research Group (ARG) is a prominent Contract Research Organization (CRO) established in 2004, dedicated to advancing drug development across various therapeutic areas, significantly in oncology, immunology, and neurology. Our mission is to provide individualized solutions that optimize the likelihood of successful drug development. At ARG, we understand that each clinical trial presents unique challenges. Hence, we adopt a highly customized approach that allows us to effectively adapt to diverse project requirements.

Our organization has achieved remarkable growth since its inception, garnering over 50 market authorizations and 85% repeat customer business, reflecting our clients' trust in our capabilities and commitment. We pride ourselves on maintaining operational excellence, aided by our state-of-the-art technology platforms and industry expertise. The ARG team is composed of dedicated professionals, offering comprehensive clinical program development services that encompass strategy formulation, trial management, and regulatory compliance. Our approach is deeply rooted in collaboration, ensuring strong communication and rapport with our partners and the patients we serve. We are committed to bringing life-changing therapies to market while prioritizing patient safety and trial integrity.